阿卡波糖對大口黑鱸高碳水化合物日糧性肝損傷的影響

    Effect of Acarbose on High Carohydrate Diet Induced Liver Injury in Largemouth Bass (Micropterus salmoides)

    • 摘要:
      目的 探明阿卡波糖對大口黑鱸(Micropterus salmoides)高碳水化合物日糧性肝損傷的影響,初篩相似功能治療藥物。
      方法 以大口黑鱸為研究對象,設置正常碳水化合物組(1.3% α-澱粉,對照)和高碳水化合物組(22.0% α-澱粉高碳水組),誘導其高碳水化合物日糧性肝損傷,隨後投喂7.5 mg/kg初始魚體質量阿卡波糖,利用大體病理學、組織病理學、酶學和流式細胞術探究阿卡波糖對高碳水化合物日糧性肝損傷的治療效果。模擬阿卡波糖的控糖原理,分析6種中草藥對高碳水化合物日糧性肝損傷的治療效果。
      結果 持續投喂高碳水化合物45 d可致大口黑鱸肝髒腫大、顏色發白、肝體比顯著增加(P < 0.05)。阿卡波糖治療15 d後,與高碳水組相比,阿卡波糖組大口黑鱸血糖含量降低1.77 mol/L,ALT和AST活性分別降低至42.00、157.67 U/L,而ALKP活性上升,有恢複到正常值的趨勢,並有效減緩肝細胞空泡化,降低肝糖原積累。流式細胞術結果顯示,高碳水組肝細胞總凋亡率最高、為4.64%;阿卡波糖組則下降至1.24%,差異顯著(P < 0.05)。與對照相比,高碳水組大口黑鱸肝組織ROS含量上升至30.94%,而阿卡波糖組降低至22.35%,且有恢複至正常水平的趨勢。6種中草藥治療大口黑鱸15 d後,均可維護其肝髒形態、降低肝體比,但各處理間差異不顯著(P > 0.05),其中肉桂治療效果更為明顯、肝體比最低(3.35%)。
      結論 阿卡波糖能有效緩解高碳水化合物日糧導致的大口黑鱸肝髒腫大、降低肝體比、緩解肝細胞凋亡和空泡化、降低肝糖原積累、減輕機體氧化應激損傷。6種中草藥中,肉桂治療效果更佳,具有與阿卡波糖類似的治療作用,可作為治療大口黑鱸高碳水化合物日糧性肝損傷的候選中草藥並進行開發利用。

       

      Abstract:
      Objective The study was conducted to investigate the effect of acarbose on high-carbohydrate dietinduced liver injury in largemouth bass and to detect similar functional therapeutic drugs in the initial screening.
      Method The largemouth bass (Micropterus salmoides) with an initial body weight of 7.25 (±1.67) g was taken as research object. First, a normal-level carbohydrate group (1.3% α-starch, CK) and a high carbohydrate group (22.0% α-starch, high carbohydrate group) were set up to induce high carbohydrate diet-induced liver injury. Then, largemouth bass with an initial body weight of 7.5 mg/kg was fed with acarbose to explore the therapeutic effects of acarbose on high carbohydrate diet-induced liver injury by using gross pathology, histopathology, enzymology, and flow cytometry. In addition, six candidate Chinese herbal medicines were screened by simulating the sugar control principle of acarbose, and their therapeutic effects on high carbohydrate dietinduced liver injury were preliminarily analyzed.
      Result Continuous feeding of high carbohydrates for 45 days could cause liver enlargement, whitening, and a significant increase in liver to body ratio in largemouth bass (P < 0.05). After 15 days of treatment with acarbose, compared with the high carbohydrate group, the blood glucose level of largemouth bass decreased by 1.77 mol/L, ALT and AST activities decreased to 42.00 U/L and 157.67 U/L, respectively, while ALKP activity increased and showed a trend of returning to normal values, effectively slowing down hepatocyte vacuolization and reducing hepatic glycogen accumulation. The results of flow cytometry showed that the total apoptosis rate of liver cells in the high carbohydrate group was the highest at 4.64% among the three groups, while that of the acarbose group significantly decreased to 1.24% (P < 0.05). In addition, compared with the control group, the ROS content in the liver tissue of largemouth bass in the high carbohydrate group increased to 30.94%, while that decreased to 22.35% in the acarbose group, showing a trend of returning to normal levels. After 15 days of treatment with 6 types of Chinese herbal medicine, the liver morphology was maintained and the liver to body ratio was reduced, however, there was no significant difference among different treatments (P > 0.05). Among them, cinnamon treatment had a more significant effect, reaching the lowest liver to body ratio at 3.35%.
      Conclusion Acarbose can effectively alleviate liver enlargement in largemouth bass caused by high carbohydrate diets, reduce liver to body ratio, alleviate liver cell apoptosis and vacuolization, reduce liver glycogen accumulation, alleviate oxidative stress damage in the body, thus protect the health of largemouth bass. Among the six traditional Chinese medicines, cinnamon has a better therapeutic effect and has a similar effect to acarbose. It can be used as a candidate herbal medicine for further development and utilization to treat high carbohydrate diet-induced liver injury in largemouth bass.

       

    /

    返回文章
    返回